Depression prevalence amongst patients with hepatitis C
Keywords:
depression, prevalence, hepatitis CAbstract
Background: Globally, hepatitis C is a serious health concern, and it is also becoming an alarming infection in our nation. The World Health Organization estimates that the hepatitis C virus infects 3% of people worldwide. Various study reported association of depression with hepatitis C virus infection. Objective: To assess the depression prevalence amongst patients with hepatitis c. Methodology: The current cross sectional study was carried out at Balochistan Institute of Psychiatry and Behavioral Sciences Quetta and Bolan Medical Complex Hospital Quetta from January 2019 to January 2020. Informed consent was taken in written from all the participants. Depressive symptomatolgy based on DSM 1V criteria was noted. A pre-designed proforma was then used to collect all the required information’s. The SPSS version 24.0 was used to input and analyze the data. Results: In the current study, a total of 120 hepatitis C patients were enrolled. There were 66 (55%) males and 54 (45%) females. Te mean age (SD) of the patients in our study was 42 (11.23) years. The overall frequency of depression amongst patients with HCV was 102 (85%).
Downloads
References
Asnis GM, De La Garza R 2nd. Department of Psychia- try and Behavioral Sciences, Albert Einstein College of Medicine, Montefiore Medical Center, Anxiety and De- pression Program, Klau Basement, 111 E. 210th Street, Bronx, New York 10467, USA. asnisarts@aol.com
Aziz S, Memon A, Tily HI, Rasheed K, Jehangir K, Quraishy MS. Prevalence of HIV, hepatitis B and C amongst health workers of Civil Hospital Karachi. J Pak Med Assoc 2002; 52: 92-4.
Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ. Depression, fatigue, and func- tional disability in patients with chronic hepatitis C. J Psychosom Res 2000; 49(5): 311 –7.
Farkkila M, Iivanainen M, Harkonen M, Laakso J, Mattson K, Niiranen A, Larsen TA, et al. Effect of interferon-gamma on biogenic amine metabolism, electroencephalographic recordings, and transient potentials. Clin Neuro- pharmacol 1988; 11: 63-67.
Fattovich G, Giustina G, Favarato S, Ruol A and Investi- gators of the Italian Association for the Study of the Liver. A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996; 24: 38-47.
Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc 2002; 52: 398-402.
Lee DH, Jamal H, Regenstein FG, Perrillo RP. Morbidity of chronic hepatitis C as seen in a tertiary care medical center. Dig Dis Sci 1997; 42: 186-91.
Maddrey WC. Safety of combination interferon alpha- 2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients. Semin Liver Dis 1999;19(Suppl 1):67-75.
McHutchisnon JG, Poynard T. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C. Semin Liver Dis 1999;19(Suppl 1):57-65.
Miyaoka H, Otsubo T, Kamijima K, Ishii M, Onuki M, Keiji M. Depression from interferon therapy in patients with hepatitis C. Am J Psychiatry 1999; 156: 1120.
Otsubo T, Miyaoka H, Kamijima K, Onuki M, Ishii M, Mitamura K. Depression during interferon therapy in chronic hepatitis C patients- a prospective study [Ar- ticle in Japanese]. Seishin Shinkeigaku Zasshi 1997; 99: 101-27.
Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P. Mood and cognitive side effects of interferon-α therapy. Semin Oncol 1998; 25(Suppl 1): 39-47.
Vignau J, Karila L, Costisella O, Canva V. Hepatitis C, interferon α and depression: Main physiopathologic hypothesis. Article in French. Service d’Addictologie, CHRU de Lille.
Woodfield DG, Harness M, Rix-Trott K, Tsuda F, Okamoto H, Mayumi M. Identification and genotyping of hepatitis C virus in injectable and oral drug users in New Zealand. Aust N Z J Med 1994; 24: 47-50.
Yates WR, Gleason O. Hepatitis C and depression. De- press Anxiety 1998; 7(4): 188 –93.
Zdilar D, Franco-Bronson K, Buchler N, Locala JA, Younossi ZM. Hepatitis C: interferon alfa, and depres- sion. Hepatology 2000;31(6):1207–11.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
